YALE UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1701-10-09
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.yale.edu
Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance
Not Applicable
Completed
- Conditions
- Opiate Dependence
- Interventions
- Other: Mobile Access
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2016-08-24
- Lead Sponsor
- Yale University
- Target Recruit Count
- 200
- Registration Number
- NCT00622596
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
Couples-based Behavioral Psychotherapy for Male Patients With Posttraumatic Stress Disorder and Alcohol Dependence
Phase 2
Withdrawn
- Conditions
- PTSDAlcohol Dependence
- Interventions
- Behavioral: Couples-based behavioral psychotherapy
- First Posted Date
- 2008-02-25
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- Yale University
- Registration Number
- NCT00622921
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
The Effect of Human Albumin Infusion on VEGF Levels in Women at Risk for Ovarian Hyperstimulation Syndrome
Not Applicable
Withdrawn
- Conditions
- Ovarian Hyperstimulation Syndrome
- Interventions
- Drug: Human Albumin InfusionDrug: Saline Infusion
- First Posted Date
- 2008-02-18
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- Yale University
- Registration Number
- NCT00617864
- Locations
- 🇺🇸
Yale Fertility Center, New Haven, Connecticut, United States
Duloxetine for the Treatment of Postpartum Depression
Not Applicable
Withdrawn
- Conditions
- Postpartum DepressionMajor Depressive Disorder
- Interventions
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2016-06-17
- Lead Sponsor
- Yale University
- Registration Number
- NCT00617045
- Locations
- 🇺🇸
Perinatal & Postpartum Research Program 142 Temple ST Suite 301, New Haven, Connecticut, United States
Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans
Early Phase 1
Completed
- Conditions
- Alcohol ConsumptionTobacco Use
- Interventions
- First Posted Date
- 2008-02-15
- Last Posted Date
- 2014-07-08
- Lead Sponsor
- Yale University
- Target Recruit Count
- 18
- Registration Number
- NCT00616746
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven Campus, West Haven, Connecticut, United States
GABA Mechanisms Underlying the Vulnerability to Alcohol Dependence
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2017-03-17
- Lead Sponsor
- Yale University
- Target Recruit Count
- 73
- Registration Number
- NCT00611767
- Locations
- 🇺🇸
VA Connecticut Healthcare System, West Haven, Connecticut, United States
Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
Early Phase 1
Completed
- Conditions
- Stem Cell Transplantation
- Interventions
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- Yale University
- Target Recruit Count
- 26
- Registration Number
- NCT00612274
- Locations
- 🇺🇸
Yale University School of Medicine, New Haven, Connecticut, United States
Effects of Atomoxetine Treatment in Humans
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2012-07-25
- Lead Sponsor
- Yale University
- Target Recruit Count
- 10
- Registration Number
- NCT00611936
GABA-glutamate Interactions and Psychosis
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- Yale University
- Target Recruit Count
- 23
- Registration Number
- NCT00611572
- Locations
- 🇺🇸
VHA Connecticut, West Haven, Connecticut, United States
The Effect of Plasma Osmolality on Brain Glutamate
Phase 1
Completed
- Conditions
- Schizophrenia
- Interventions
- Drug: furosemide, Na supplements
- First Posted Date
- 2008-02-11
- Last Posted Date
- 2016-02-09
- Lead Sponsor
- Yale University
- Target Recruit Count
- 30
- Registration Number
- NCT00611741
- Locations
- 🇺🇸
34 Park Street, CMHC, New Haven, Connecticut, United States
© Copyright 2025. All Rights Reserved by MedPath